Abstract

Background

The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

Main Body

This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals.

Conclusion

Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.

Details

Title
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Author
Toyohara, Jun 1 ; Al-Qahtani, Mohammed 2 ; Huang, Ya-Yao 3 ; Cazzola, Emiliano 4 ; Todde, Sergio 5 ; Furumoto, Shozo 6 ; Mikolajczak, Renata 7 ; Decristoforo, Clemens 8 ; Gillings, Nic 9 ; Yang, Min 10 ; Reilly, Raymond 11 ; Duatti, Adriano 12 ; Denkova, Antonia 13 ; Schirrmacher, Ralf 14 ; Carlucci, Giuseppe 15 ; Seimbille, Yann 16 ; Liu, Zhaofei 17 ; Ellis, Beverley 18 ; Cornelissen, Bart T. 19 ; Kopka, Klaus 20   VIAFID ORCID Logo  ; Bernardes, Emerson 21 

1  Tokyo Metropolitan Institute of Gerontology, PET Radiopharmaceutical Sciences, Research Team for Neuroimaging, Tokyo, Japan (GRID:grid.420122.7) (ISNI:0000 0000 9337 2516) 
2  King Faisal Specialist Hospital and Research Center (KFSHRC), Cyclotron and Radiopharmaceuticals Department, Riyadh, Saudi Arabia (GRID:grid.415310.2) (ISNI:0000 0001 2191 4301) 
3  National Taiwan University, Molecular Imaging Center, Taipei, Taiwan (GRID:grid.19188.39) (ISNI:0000 0004 0546 0241) 
4  Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Sacro Cuore-Don Calabria Hospital, Negrar (Vr), Italy (GRID:grid.19188.39); Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Ospedale Sacro Cuore-Don Calabria, Negrar (Vr), Italia (GRID:grid.414603.4) 
5  University of Milano-Bicocca, Tecnomed Foundation, Monza, Italy (GRID:grid.7563.7) (ISNI:0000 0001 2174 1754) 
6  Tohoku University, Cyclotron and Radioisotope Center (CYRIC), Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943) 
7  National Centre for Nuclear Research (NCBJ), Radioisotope Centre POLATOM, Otwock, Poland (GRID:grid.450295.f) (ISNI:0000 0001 0941 0848); NARODOWE CENTRUM BADAŃ JĄDROWYCH (NCBJ), Ośrodek Radioizotopów POLATOM, Otwock, Poland (GRID:grid.450295.f) (ISNI:0000 0001 0941 0848) 
8  Medical University of Innsbruck, Department of Nuclear Medicine, Innsbruck, Austria (GRID:grid.5361.1) (ISNI:0000 0000 8853 2677) 
9  Copenhagen University Hospital Rigshospitalet, Department of Clinical Physiology and Nuclear Medicine, Copenhagen, Denmark (GRID:grid.475435.4) 
10  Jiangsu Institute of Nuclear Medicine, NHC Key Laboratory of Nuclear Medicine, Wuxi, China (GRID:grid.412676.0) (ISNI:0000 0004 1799 0784) 
11  University of Toronto, Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
12  University of Ferrara, Department of Chemical, Pharmaceutical and Agricultural Sciences, Ferrara, Italy (GRID:grid.8484.0) (ISNI:0000 0004 1757 2064); Farmaceutiche e Agrarie Università di Ferrara, Dipartimento di Scienze Chimiche, Ferrara, Italia (GRID:grid.8484.0) (ISNI:0000 0004 1757 2064) 
13  Delft University of Technology, Department of Radiation Science and Technology, Delft, The Netherlands (GRID:grid.5292.c) (ISNI:0000 0001 2097 4740) 
14  University of Alberta, Department of Oncology, Cross Cancer Institute, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X) 
15  University of California, Los Angeles (UCLA), Department of Molecular and Medical Pharmacology, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718) 
16  University Medical Center Rotterdam, Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X) 
17  Peking University Health Science Centre, Medical Isotopes Research Center, Department of Radiation Medicine, School of Basic Medical Sciences, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319) 
18  Manchester University NHS Foundation Trust, Manchester, UK (GRID:grid.498924.a) (ISNI:0000 0004 0430 9101) 
19  University Medical Center, University of Groningen, Department of Nuclear Medicine and Molecular Imaging, Groningen (UMCG), Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981) 
20  Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiopharmaceutical Cancer Research, Dresden, Germany (GRID:grid.40602.30) (ISNI:0000 0001 2158 0612) 
21  Energy and Nuclear Research Institute (IPEN-CNEN/SP), Cidade Universitária, São Paulo, Brazil (GRID:grid.466806.a) (ISNI:0000 0001 2104 465X); Instituto de Pesquisas Energéticas e Nucleares (IPEN-CNEN/SP), Cidade Universitária, São Paulo, Brasil (GRID:grid.466806.a) (ISNI:0000 0001 2104 465X) 
Publication year
2022
Publication date
Dec 2022
Publisher
Springer Nature B.V.
e-ISSN
2365-421X
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1186/s41181-022-00177-w
ProQuest document ID
2719936331
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.